Glaxo kidney cancer drug wins US panel support - Reuters PDF Print
ReutersThe drugmaker is seeking to market Votrient, also known by its chemical name pazopanib, to treat advanced renal cell carcinoma. If approved, it would be the

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.